Gene Expression Patterns in Advanced Human Cervical Cancer
Overview
Oncology
Authors
Affiliations
The purpose of this study was to evaluate gene expression patterns in human cervical tumors by extent of lymph node metastases at diagnosis. Pretreatment whole-body fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging was performed in eight patients with invasive squamous cell carcinoma of the cervix to evaluate the extent of lymph nodes metastases. Pretreatment tumor tissue samples were subjected to laser-capture microdissection, and isolated RNA was linearly amplified and hybridized to Affymetrix Human U95A GeneChip microarrays. Molecular FDG-PET imaging revealed that three patients had lymph node involvement in the supraclavicular region and five patients did not. Microarray data were segregated into two groups based on the extent of regional lymph node involvement. Supervised clustering analysis identified 75 of about 12,000 gene transcripts represented on the array whose average expression was at least threefold different. We identified 12 of the 75 transcripts that demonstrated a statistically significant difference in expression between the two patient groups (P < 0.05). Five transcripts were upregulated and seven downregulated. Both overall and cause-specific survivals were different between these two patient groups (P= 0.006). This limited data set identified candidate biomarkers of extent of lymph node metastases that correlated with poor survival outcome.
Enhanced targeted treatment of cervical cancer using nanoparticle-based doxycycline delivery system.
Anjum S, Akhtar A, Aldaqal S, Abduh M, Ahmad H, Mustafa R Sci Rep. 2025; 15(1):2318.
PMID: 39824865 PMC: 11742058. DOI: 10.1038/s41598-024-84203-8.
Validated limited gene predictor for cervical cancer lymph node metastases.
Bloomstein J, von Eyben R, Chan A, Rankin E, Fregoso D, Wang-Chiang J Oncotarget. 2020; 11(24):2302-2309.
PMID: 32595829 PMC: 7299532. DOI: 10.18632/oncotarget.27632.
Cosper P, McNair C, Gonzalez I, Wong N, Knudsen K, Chen J Int J Cancer. 2019; 146(7):2047-2058.
PMID: 31732968 PMC: 8177718. DOI: 10.1002/ijc.32793.
Li X, Cai Y Int J Mol Sci. 2018; 19(11).
PMID: 30445744 PMC: 6275080. DOI: 10.3390/ijms19113607.
Down-regulation of IFITM1 and its growth inhibitory role in cervical squamous cell carcinoma.
Zheng W, Zhao Z, Yi X, Zuo Q, Li H, Guo X Cancer Cell Int. 2017; 17:88.
PMID: 29051711 PMC: 5633880. DOI: 10.1186/s12935-017-0456-0.